AIG
BBIO icon

American International Group’s BridgeBio Pharma BBIO Stock Holding History

American International Group’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-57,491
Closed -$1.78M – 303
2024
Q1 		$1.78M Buy
57,491
+565
+1% +$19.2K 0.01% 1055
2023
Q4 		$2.3M Sell
56,926
-230
-0.4% -$6.91K 0.01% 956
2023
Q3 		$1.51M Sell
57,156
-920,656
-94% -$26.1M 0.01% 1047
2023
Q2 		$16.8M Sell
977,812
-1,726,562
-64% -$26M 0.1% 164
2023
Q1 		$44.8M Sell
2,704,374
-1,015,711
-27% -$11.8M 0.29% 47
2022
Q4 		$28.3M Buy
3,720,085
+419
+0% +$4.01K 0.2% 85
2022
Q3 		$37M Buy
3,719,666
+702
+0% +$7.29K 0.27% 53
2022
Q2 		$33.8M Sell
3,718,964
-3,716
-0.1% -$31.1K 0.23% 68
2022
Q1 		$37.8M Sell
3,722,680
-3,708
-0.1% -$38.1K 0.21% 76
2021
Q4 		$62.2M Sell
3,726,388
-2,516
-0.1% -$106K 0.31% 47
2021
Q3 		$175M Sell
3,728,904
-1,398
-0% -$74.9K 0.93% 9
2021
Q2 		$227K Buy
3,730,302
+5,468
+0.1% +$312K 0.77% 20
2021
Q1 		$229K Buy
3,724,834
+382,500
+11% +$25M 0.8% 21
2020
Q4 		$238K Sell
3,342,334
-2,277,594
-41% -$110M 0.88% 16
2020
Q3 		$183M Sell
5,619,928
-991
-0% -$31.2K 0.88% 27
2020
Q2 		$183M Sell
5,620,919
-298,327
-5% -$9.09M 0.88% 32
2020
Q1 		$172M Sell
5,919,246
-825,146
-12% -$25.6M 0.94% 29
2019
Q4 		$236M Sell
6,744,392
-2,119
-0% -$58.7K 0.91% 34
2019
Q3 		$145M Buy
6,746,511
+14,267
+0.2% +$395K 0.58% 36
2019
Q2 		$182M Buy
+6,732,244
New +$184M 0.71% 34

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's BBIO Position: Q2 2024 in Review

American International Group sold out of BridgeBio Pharma (BBIO) in Q2 2024, closing a stake of 57,491 shares — an estimated $1.78M sold.

American International Group first reported a position in BBIO in Q2 2019 and held it in 20 quarters. The position peaked at $236M in Q4 2019. 251 funds tracked by Wall St. Rank hold BBIO as of Q2 2024.

  • American International Group reported no remaining BridgeBio Pharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 57,491 BridgeBio Pharma shares in Q2 2024, an estimated $1.78M.
  • American International Group first reported a position in BridgeBio Pharma in Q2 2019 and held it in 20 quarters.
  • American International Group's BridgeBio Pharma position peaked at $236M in Q4 2019.
  • 251 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.